Birdwatch Note
2023-11-01 11:47:05 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Ventilation for COVID is less effective than other respiratory diseases. COVID - although spread via respiration - has major circulatory effects including reducing the amount of oxygen blood can carry. Damage to blood cells: https://pubs.acs.org/doi/10.1021/acs.jproteome.0c00606 Red Blood Cell exchange improves survival rate: https://www.frontiersin.org/articles/10.3389/fmed.2022.899593/full
Written by 091CDA44805D26E7D1CEDD40F91BD9EB5752ECCA1A5CEEE319C7D1AFED15F8A1
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1719468796711403873
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1719682467748278519
- noteId - 1719682467748278519
- participantId -
- noteAuthorParticipantId - 091CDA44805D26E7D1CEDD40F91BD9EB5752ECCA1A5CEEE319C7D1AFED15F8A1 Participant Details
- createdAtMillis - 1698839225123
- tweetId - 1719468796711403873
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Ventilation for COVID is less effective than other respiratory diseases. COVID - although spread via respiration - has major circulatory effects including reducing the amount of oxygen blood can carry. Damage to blood cells: https://pubs.acs.org/doi/10.1021/acs.jproteome.0c00606 Red Blood Cell exchange improves survival rate: https://www.frontiersin.org/articles/10.3389/fmed.2022.899593/full
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-11-01 11:47:05 UTC (1698839225123) |
1969-12-31 23:59:59 UTC (-1) |
2023-11-02 07:47:06 UTC (1698911226426) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-11-01 08:13:22 -0500 | Rating Details | |
| 2023-11-01 08:03:23 -0500 | Rating Details | |
| 2023-11-01 07:57:51 -0500 | Rating Details | |
| 2023-11-01 07:38:10 -0500 | Rating Details | |
| 2023-11-01 07:37:47 -0500 | Rating Details | |
| 2023-11-01 06:55:07 -0500 | Rating Details | |
| 2023-11-01 06:54:22 -0500 | Rating Details | |
| 2023-11-03 16:12:28 -0500 | Rating Details | |
| 2023-11-03 01:45:45 -0500 | Rating Details | |
| 2023-11-02 13:31:20 -0500 | Rating Details | |
| 2023-11-02 12:33:32 -0500 | Rating Details | |
| 2023-11-02 11:49:56 -0500 | Rating Details | |
| 2023-11-02 09:54:53 -0500 | Rating Details | |
| 2023-11-02 09:05:23 -0500 | Rating Details | |
| 2023-11-02 08:13:26 -0500 | Rating Details | |
| 2023-11-02 08:11:16 -0500 | Rating Details | |
| 2023-11-02 08:06:08 -0500 | Rating Details | |
| 2023-11-02 07:54:30 -0500 | Rating Details | |
| 2023-11-02 07:28:48 -0500 | Rating Details | |
| 2023-11-02 06:45:19 -0500 | Rating Details | |
| 2023-11-02 06:44:04 -0500 | Rating Details | |
| 2023-11-02 06:14:19 -0500 | Rating Details | |
| 2023-11-02 05:21:27 -0500 | Rating Details | |
| 2023-11-02 04:56:06 -0500 | Rating Details | |
| 2023-11-02 04:03:38 -0500 | Rating Details | |
| 2023-11-02 03:46:19 -0500 | Rating Details | |
| 2023-11-02 03:26:10 -0500 | Rating Details | |
| 2023-11-02 02:40:43 -0500 | Rating Details | |
| 2023-11-02 01:35:40 -0500 | Rating Details | |
| 2023-11-02 01:30:38 -0500 | Rating Details | |
| 2023-11-02 01:17:39 -0500 | Rating Details | |
| 2023-11-02 00:58:14 -0500 | Rating Details | |
| 2023-11-02 00:33:27 -0500 | Rating Details | |
| 2023-11-01 23:28:22 -0500 | Rating Details | |
| 2023-11-01 23:12:03 -0500 | Rating Details | |
| 2023-11-01 21:26:40 -0500 | Rating Details | |
| 2023-11-01 20:02:03 -0500 | Rating Details | |
| 2023-11-01 18:49:38 -0500 | Rating Details | |
| 2023-11-01 18:37:37 -0500 | Rating Details | |
| 2023-11-01 18:14:13 -0500 | Rating Details | |
| 2023-11-01 17:29:46 -0500 | Rating Details | |
| 2023-11-01 17:25:33 -0500 | Rating Details | |
| 2023-11-01 16:45:46 -0500 | Rating Details | |
| 2023-11-01 16:44:42 -0500 | Rating Details | |
| 2023-11-01 16:38:51 -0500 | Rating Details | |
| 2023-11-01 16:17:22 -0500 | Rating Details | |
| 2023-11-01 16:06:21 -0500 | Rating Details | |
| 2023-11-01 15:04:54 -0500 | Rating Details | |
| 2023-11-01 14:57:29 -0500 | Rating Details | |
| 2023-11-01 14:37:02 -0500 | Rating Details | |
| 2023-11-01 14:23:58 -0500 | Rating Details | |
| 2023-11-01 14:10:26 -0500 | Rating Details | |
| 2023-11-01 14:08:37 -0500 | Rating Details | |
| 2023-11-01 13:58:56 -0500 | Rating Details | |
| 2023-11-01 13:53:44 -0500 | Rating Details | |
| 2023-11-01 13:48:58 -0500 | Rating Details | |
| 2023-11-01 13:46:46 -0500 | Rating Details | |
| 2023-11-01 13:11:05 -0500 | Rating Details | |
| 2023-11-01 12:59:09 -0500 | Rating Details | |
| 2023-11-01 12:58:07 -0500 | Rating Details | |
| 2023-11-01 12:45:33 -0500 | Rating Details | |
| 2023-11-01 12:35:44 -0500 | Rating Details | |
| 2023-11-01 12:22:14 -0500 | Rating Details | |
| 2023-11-01 12:21:54 -0500 | Rating Details | |
| 2023-11-01 12:10:29 -0500 | Rating Details | |
| 2023-11-01 11:53:34 -0500 | Rating Details | |
| 2023-11-01 11:41:10 -0500 | Rating Details | |
| 2023-11-01 11:40:37 -0500 | Rating Details | |
| 2023-11-01 11:39:17 -0500 | Rating Details | |
| 2023-11-01 11:28:12 -0500 | Rating Details | |
| 2023-11-01 11:26:35 -0500 | Rating Details | |
| 2023-11-01 11:08:40 -0500 | Rating Details | |
| 2023-11-01 11:07:48 -0500 | Rating Details | |
| 2023-11-01 11:00:35 -0500 | Rating Details | |
| 2023-11-01 10:55:23 -0500 | Rating Details | |
| 2023-11-01 10:26:11 -0500 | Rating Details | |
| 2023-11-01 10:16:04 -0500 | Rating Details | |
| 2023-11-01 10:06:21 -0500 | Rating Details | |
| 2023-11-01 10:01:38 -0500 | Rating Details | |
| 2023-11-01 09:58:28 -0500 | Rating Details | |
| 2023-11-01 09:54:23 -0500 | Rating Details | |
| 2023-11-01 09:52:06 -0500 | Rating Details | |
| 2023-11-01 09:44:09 -0500 | Rating Details | |
| 2023-11-01 09:37:01 -0500 | Rating Details | |
| 2023-11-01 09:34:17 -0500 | Rating Details | |
| 2023-11-01 09:32:46 -0500 | Rating Details | |
| 2023-11-01 09:19:12 -0500 | Rating Details | |
| 2023-11-01 09:03:32 -0500 | Rating Details | |
| 2023-11-01 09:03:08 -0500 | Rating Details | |
| 2023-11-01 08:57:22 -0500 | Rating Details | |
| 2023-11-01 08:52:26 -0500 | Rating Details | |
| 2023-11-01 08:49:30 -0500 | Rating Details | |
| 2023-11-01 08:48:42 -0500 | Rating Details | |
| 2023-11-01 08:45:53 -0500 | Rating Details | |
| 2023-11-01 08:42:57 -0500 | Rating Details | |
| 2023-11-01 08:42:32 -0500 | Rating Details | |
| 2023-11-01 08:39:57 -0500 | Rating Details | |
| 2023-11-01 08:35:29 -0500 | Rating Details | |
| 2023-11-01 08:34:35 -0500 | Rating Details | |
| 2023-11-01 08:24:29 -0500 | Rating Details | |
| 2023-11-01 08:11:56 -0500 | Rating Details | |
| 2023-11-01 08:10:12 -0500 | Rating Details | |
| 2023-11-01 08:05:32 -0500 | Rating Details | |
| 2023-11-01 08:00:08 -0500 | Rating Details | |
| 2023-11-01 07:58:09 -0500 | Rating Details | |
| 2023-11-01 07:53:47 -0500 | Rating Details | |
| 2023-11-01 07:44:18 -0500 | Rating Details | |
| 2023-11-01 07:29:07 -0500 | Rating Details | |
| 2023-11-01 07:19:22 -0500 | Rating Details | |
| 2023-11-01 06:48:15 -0500 | Rating Details | |
| 2023-11-04 14:44:40 -0500 | Rating Details | |
| 2023-11-04 13:51:51 -0500 | Rating Details | |
| 2023-11-03 23:04:07 -0500 | Rating Details | |
| 2023-11-10 04:02:37 -0600 | Rating Details |